Skip to main content

Table 2 Primary and secondary outcome parameters

From: Influence of in-line microfilters on systemic inflammation in adult critically ill patients: a prospective, randomized, controlled open-label trial

 

In-line microfilter group

Control group

p value

All patients

   

 n

252

252

 

Primary outcome parameter

   

 Days with SIRS (days)

2 (0.8–4.7)

1.8 (0.7–4.4)

0.62

Secondary outcome parameters

   

 Patients with SIRS (n/%)

251 (99.6)

244 (96.8)

0.04*

 SIRS criteria per SIRS day (n)

2 (2–2)

2 (2–3)

0.77

 New ALI/ARDS (n/%)

8 (3.2)

6 (2.4)

0.77

 Duration of invasive mechanical ventilation (days)

0.5 (0.1–2)

0.8 (0.3–2.7)

0.14

 Length of stay in the ICU (days)

2.3 (1–5.2)

2 (1–4.7)

0.53

 ICU mortality (n/%)

30 (11.9)

28 (11.1)

0.89

Post hoc analysis: ICU stay > 7 days

   

 n

37

35

 

 Days with SIRS (days)

8 (6–16)

9 (6–17)

0.76

 Patients with SIRS (n/%)

37 (100)

35 (100)

1

 SIRS criteria per SIRS day (n)

2 (2–3)

2 (2–3)

0.89

 New ALI/ARDS (n/%)

7 (18.9)

4 (11.4)

0.52

 Duration of invasive mechanical ventilation (days)

4 (1–10)

5 (3–9)

0.89

 Length of stay in the ICU (days)

10 (8–17)

12 (9–19)

0.64

 ICU mortality (n/%)

9 (24.3)

5 (14.3)

0.38

  1. SIRS, systemic inflammatory response syndrome; ALI/ARDS, acute lung injury/acute respiratory distress syndrome; ICU, intensive care unit
  2. * Significant difference between groups